Lipid nanocapsules containing the non-ionic surfactant Solutol HS15 inhibit the transport of calcium through hyperforin-activated channels in neuronal cells

Neuropharmacology
Sylvain ChauvetAlexandre Bouron

Abstract

Hyperforin is described as a natural antidepressant inhibiting the reuptake of neurotransmitters and also activating cation channels. However the blood-brain barrier limits the access to the brain of this biomolecule. To circumvent this problem it was envisaged to encapsulate hyperforin into biomimetic lipid nano-carriers like lipid nanocapsules (LNCs). When testing the safety of 25 nm LNCs it appeared that they strongly blocked hyperforin-activated Ca(2+) channels of cultured cortical neurons. This inhibition was due to one of their main component: solutol HS15 (polyoxyethylene-660-12-hydroxy stearate), a non-ionic soluble surfactant. Solutol HS15 rapidly depresses in a concentration-dependent manner the entry of Ca(2+) through hyperforin-activated channels without influencing store-operated channels. This effect is mimicked by Brij58 but not by PEG600, indicating that the lipid chain of Solutol HS15 is important in determining its effects on the channels. The inhibition of the Ca(2+) fluxes depends on the cellular cholesterol content; it is stronger after depleting cholesterol with methyl-β-cyclodextrin and is nearly absent on cells cultured in a cholesterol-rich medium. When chronically applied for 24 h, Solutol HS15 slightl...Continue Reading

References

Jul 7, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M WonnemannW E Müller
Sep 5, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bhagwant D RegeJames E Polli
Sep 7, 2002·Life Sciences·Netta RozMoshe Rehavi
Nov 29, 2002·Psychopharmacology·Luigi CervoSilvio Caccia
Feb 3, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Klaus LindeCynthia Mulrow
Feb 22, 2005·British Journal of Pharmacology·Kristina TreiberWalter E Müller
Mar 25, 2005·Physiological Reviews·Anant B Parekh, James W Putney
Apr 1, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alf Lamprecht, Jean-Pierre Benoit
Oct 4, 2006·Expert Opinion on Drug Metabolism & Toxicology·Anna Seelig, Grégori Gerebtzoff
Jul 31, 2007·Biochemical and Biophysical Research Communications·Robert Kraft
Dec 7, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Arnaud BéduneauJean-Pierre Benoit
May 5, 2009·International Journal of Pharmaceutics·N T HuynhJ P Benoit
Jul 28, 2009·Biochimica Et Biophysica Acta·Xiaochun Li-BlatterAnna Seelig
Aug 25, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·E RogerJ-P Benoit
Oct 23, 2009·Journal of Neurochemistry·Peng TuAlexandre Bouron
Aug 26, 2011·Biochimica Et Biophysica Acta·Julien GibonAlexandre Bouron
Jan 10, 2012·The International Journal of Neuropsychopharmacology·Julien GibonAlexandre Bouron
Feb 7, 2013·Pharmacological Reviews·Hywel D WilliamsChristopher J H Porter
Nov 12, 2014·Molecular Psychiatry·K Griesi-OliveiraA R Muotri
Dec 17, 2014·Scientific Reports·Thomas S SellAndreas Beck

❮ Previous
Next ❯

Citations

Jan 9, 2019·Frontiers in Molecular Neuroscience·Bartłomiej PochwatGabriel Nowak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Advances in Second Messenger and Phosphoprotein Research
R S Lewis
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Yoshihiro Baba
American Journal of Physiology. Lung Cellular and Molecular Physiology
T Stevens
American Journal of Physiology. Lung Cellular and Molecular Physiology
Roger Marthan
© 2021 Meta ULC. All rights reserved